U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...

Nektar Therapeutics is fairly valued based on rNPV modeling, but multiple near-term catalysts could drive upside. Learn why ...

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

The Victoria, B.C.-based company is developing EP-104IAR for osteoarthritis pain and a new formulation for eosinophilic ...

The Phase I trial of ADC CX-2051 in colorectal cancer will continue, based on a decision made by a safety committee.

CNW/ - (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") today announced its financial results for the quarter ended June 30, ...

Detailed price information for Roivant Sciences Ltd (ROIV-Q) from The Globe and Mail including charting and trades.

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today provided an update on the CX-2051 Phase 1 stud ...

Detailed price information for Roivant Sciences Ltd (ROIV-Q) from The Globe and Mail including charting and trades.

Publisher THQ Nordic and developer Tarsier Studios announced the cooperative horror adventure game, REANIMAL, will launch for the Nintendo Switch 2, PlayStation 5, Xbox Series X|S, and PC via ...

Travel tech company Yatra reported a consolidated net profit of INR 16 Cr in Q1 FY26, up 300% from INR 4 Cr reported in the year ago period.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On August 4, BMO Capital lifted the price target on the company’s ...